Molecular Formula | C19H26N2O3 |
Molar Mass | 330.42 |
Density | 1.183±0.06 g/cm3(Predicted) |
Boling Point | 543.9±30.0 °C(Predicted) |
Solubility | DMSO: ≥ 300 mg/mL |
pKa | 15.23±0.29(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.026 ml | 15.132 ml | 30.264 ml |
5 mM | 0.605 ml | 3.026 ml | 6.053 ml |
10 mM | 0.303 ml | 1.513 ml | 3.026 ml |
5 mM | 0.061 ml | 0.303 ml | 0.605 ml |
Use | 1-[1-[(5-methoxy-1H-indole-2-yl) carbonyl] piperidine -4-yl]-2-methylprop-2-ol is a compound with 17 β HSD type5 selective inhibitory activity, A compound useful as a therapeutic agent for prostate hypertrophy and/or prostate cancer. |
biological activity | ASP-9521 is a selective, oral bioavailable 17beta-hydroxyysteroid dehydrogenase type 5 (17β-HSD5) inhibitor. |
target | TargetValue 17β-HSD5 () |
Target | Value |